<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03161509</url>
  </required_header>
  <id_info>
    <org_study_id>0563-16-RMB</org_study_id>
    <nct_id>NCT03161509</nct_id>
  </id_info>
  <brief_title>Pharmacokinetics of Paracetamol and Antiepileptic Drugs After Sleeve Gastrectomy</brief_title>
  <official_title>Effect of Sleeve Gastroctomy on Pharmacokinetics of Paracetamol and Antiepileptic Drugs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rambam Health Care Campus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sleeve gastrectomy may affect drug pharmacokinetics in several potential ways. We will
      measure pharmakokinetics of paracetamol and antiepileptic drugs before and 6 months after
      sleeve gastrectomy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sleeve gastrectomy may affect drug pharmacokinetics in several potential ways. We will
      measure pharmakokinetics of paracetamol (in consenting subjects that are undergoing sleeve
      gastrectomy) and antiepileptic drugs (in consenting subjects that are chronically treated by
      a stable dose) before and 6 months after sleeve gastrectomy in 10 subjects.

      Blood tests will be taken for drug levels before and 4-8 times after the subject takes the
      drug. A pharmacokinetic curve will be calculated and compared for each subject between prior
      to surgery and after surgery.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">July 2017</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>All participants will undergo blood tests for pharmacokinetic of paracetamol before and 6 months after sleeve gastrectomy</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pharmacokinetic curve of paracetamol or antiepileptic drug: AUC</measure>
    <time_frame>8 hours</time_frame>
    <description>sequential measurement of paracetamol or antiepileptic drug (carbamazepine, lamotrigine, phenytoin or valproic acid), AUC</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Bariatric Surgery Candidate</condition>
  <arm_group>
    <arm_group_label>paracetamol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>10 participants will undergo measurement of paracetamol levels before and after sleeve gastrectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>antiepileptic drug</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Up to 10 participants in each drug (up to 4 medications, total of up to 40 participants) will undergo measurement of levels of their chronic medication after a dose before and after sleeve gastrectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Paracetamol</intervention_name>
    <description>single dose of 1 gr paracetamol</description>
    <arm_group_label>paracetamol</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antiepileptic (either carbamazepine, lamotrigine, phenytoin or valproic acid)</intervention_name>
    <description>Single dose of antiepileptic drug (either carbamazepine, lamotrigine, phenytoin or valproic acid) for which the participant is taking chronically in stable dose</description>
    <arm_group_label>antiepileptic drug</arm_group_label>
    <other_name>Antiepileptic</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. BMI over 30 and eligible for sleeve gastrectomy

          2. Mentally capable for consent

          3. (for the antiepileptic drug intervention) chronic stable treatment of antiepileptic
             drug

        Exclusion Criteria:

          1. Gastrointestinal illness impairing absorption

          2. renal failure (glomerular filtration rate&lt;45)

          3. liver cirrhosis

          4. heart failure (New York Heart Association class III or IV)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Irit Hochberg, MD/PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Healthcare Campus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Irit Hochberg, MD/PhD</last_name>
    <phone>+972-4-7772150</phone>
    <email>i_hochberg@rambam.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sigalit Cohen</last_name>
    <phone>+972-4-7771606</phone>
    <email>si_cohen@rambam.health.gov.il</email>
  </overall_contact_backup>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 27, 2017</study_first_submitted>
  <study_first_submitted_qc>May 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2017</study_first_posted>
  <last_update_submitted>May 28, 2017</last_update_submitted>
  <last_update_submitted_qc>May 28, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Rambam Health Care Campus</investigator_affiliation>
    <investigator_full_name>Irit HOCHBERG MD</investigator_full_name>
    <investigator_title>Principle investigator, Attending physician in Institute of Endocrinology, Diabetes and Metabolism</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Carbamazepine</mesh_term>
    <mesh_term>Lamotrigine</mesh_term>
    <mesh_term>Valproic Acid</mesh_term>
    <mesh_term>Phenytoin</mesh_term>
    <mesh_term>Anticonvulsants</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>IPD will be shared upon request</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

